GLP1R and myocardial infarction: Early clinical studies also suggested that GLP-1 agonists have positive effects on cardiovascular biomarkers, such as high-sensitivity C-reactive protein and plasminogen activator inhibitor-1 [12, 13], and improve regional and overall left ventricular function in patients with acute myocardial infarction and severe systolic dysfunction after successful primary angioplasty [14].